Objective: Several studies have demonstrated favorable results despite patient-prosthesis mismatch after aortic valve replacement with the use of third generation prostheses. Our aim was to determine whether this mismatch is always tolerable. Methods: A clinical-echocardiographic study has been performed in 339 consecutive patients who underwent aortic valve replacement because of aortic stenosis. In-hospital outcome and left ventricular mass index regression (1st month-1st year) were analyzed in the presence or absence of mismatch (indexed effective orifice area %0.85 cm 2 /m 2 ). The influence of high degrees of preoperative left ventricular mass on in-hospital mortality has also been evaluated. Left ventricular mass index was considered increased if the calculated value was over the superior quartile of the frequency distribution of all the values observed in both sexes. Results: Mismatch was found in 38% of the patients. In the absence of mismatch, the absolute mass regression was proportional to the preoperative left ventricular mass. This regression was higher in patients with increased left ventricular mass indexed (vs not increased): K38.0G7.8 vs K8.8G4.7 g/m 2 , p!0.01 (1st month) and K67.7G16.9 vs K23.5G6.7 g/m 2 , p!0.05 (1st year). Mass regression was impaired in the presence of mismatch, particularly, in patients with previously increased left ventricular mass: K8.2G11.6 vs K5.6G 6.3 g/m 2 (pZ0.83) and K24.6G12.6 vs K11.7G10.5 g/m 2 (pZ0.54). This worse regression was reflected on a 100% incidence of residual hypertrophy at follow-up (1st month-1st year). In the presence of mismatch, increased ventricular mass was associated with higher mortality: 14.7% vs 2.1% (p!0.01). In the absence of mismatch, ventricular mass was not associated with mortality: 4.1 vs 2.5% (pZ0.55). Conclusions: In patients with severe ventricular hypertrophy it may be important to elude patient-prosthesis mismatch to avoid a significant increase in mortality and improve ventricular mass regression. Mismatch may be tolerable in those patients with lesser degree of hypertrophy. q
Introduction
Patient-prosthesis mismatch (PPM) is presented when the prothesis used for aortic valve replacement is too small in relation to patient body size. This subject is still a matter of controversy in our modern cardiac surgery. On one hand, several studies have demonstrated favourable results despite the occurrence of PPM after aortic valve replacement with the use of third generation prostheses [1] [2] [3] . On the other hand, other studies have found this mismatch as a strong and independent predictor of shortterm and late mortality among patients undergoing aortic valve replacement, and its impact was related both to its degree of severity and the status of left ventricular function [4, 5] .
The degree of preoperative left ventricular hypertrophy may also play an important role on this mortality. Several studies have reported the early and late prognostic importance of preoperatively increased left ventricular mass index (LVMI) in aortic valve surgery [6, 7] . As PPM is also a predictor of mortality and it can be responsible for postoperative high transvalvular pressure gradients and impairment of left ventricular mass regression, the influence of severe preoperative left ventricular hypertrophy on patients with PPM may be of relevance in aortic valve replacement. Unlike left ventricular dysfunction, preoperative ventricular hypertrophy has seldom been addressed as a prognostic factor in relation to PPM. So, the aim of our study was to determine whether PPM is always tolerable in our current practice and the potential influence of a previous increased LVMI on aortic valve replacement outcomes in the presence of PPM.
Materials and methods

Patient study group
Between Mar-94 and Nov-01 409 consecutive patients underwent isolated aortic valve replacement. They were identified through a prospectively mantained surgical database (PATS, Cormedica w, Palex) and medical charts were reviewed retrospectively in order to confirm information and complete missing data of interest. Only those patients with pure or predominant aortic valve stenosis have been included in the study. Exclusion criteria were: significant aortic valve insufficiency, coronary artery bypass surgery and other valve or aortic surgical procedures. Emergent operations, infectious endocarditis and patients without preoperative echocardiographic data or with previous aortic valve replacement were also excluded. The medical records of 339 consecutive patients (189 men and 150 women) who fulfilled the entry criteria for the study were reviewed, including demographics, preoperative clinical data, echocardiographic results, cardiac catheterization hemodynamics, operative and postoperative data.
Echocardiography
Preoperative 2D and Doppler echocardiographic assessment was performed in all patients. Postoperative evaluation was obtained in 312 patients at 1st month and in 190 patients at least one echocardiogram was performed between 6 months and one year postoperatively (median: 10 months, interquartile range: 7-11 months). Most of echocardiographic data were collected from the Section of Echocardiography database in our hospital.
Diastolic measurements of left ventricular internal diameter (LVID), interventricular septal thickness (IVST) and posterior wall thickness (PWT) (in millimeters) were used to calculate LVMI by means of the formula described by Devereux and colleagues [8, 9] :
Body surface area:
These measurements were calculated by M-mode guided by 2D echocardiography. According to this author, LVMI was considered as increased if greater than 134 g/m 2 in men and greater than 110 g/m 2 in women. Postoperative residual left ventricular hypertrophy was also defined as a LVMI higher than 134 g/m 2 in males and higher than 110 g/m 2 in females. But for the purpose of our study, we have evaluated the influence of higher degrees of preoperative LVMI on in-hospital mortality and a higher cutoff point of LVMI values was considered, dividing the global group of patients into two subgroups: with and without significant increased LVMI. This cut-off point was established at the first value of the superior quartile of the frequency distribution of LVMI values in both sexes. Thus, according to this value, preoperative increased LVMI was present when LVMI was O226 g/m 2 in males and O216 g/m 2 in females. Combined wall thickness was considered as the sum of IVST and PWT and relative wall thickness as the ratio of Combined Wall Thickness to LVID.
Left ventricular ejection fraction (LVEF) was calculated by 2D echocardiography with Simpson's method. Aortic valve hemodynamics were assessed by Doppler echocardiographic examination. The left ventricular outflow tract area was calculated from the diameter of the outflow tract measured from a two-dimensional image in early systole. Flow velocities in the outflow tract (2.5-MHz pulsed Doppler) were recorded from an apical long-axis view, and the maximal instantaneous aortic valve gradient was calculated from the peak aortic Doppler velocity by the modified Bernoulli equation. Mean aortic pressure gradient and time velocity integral of the aortic and left ventricular outflow tract flow velocities were measured. The velocity-time integral of blood flow in the left ventricular outflow tract was determined to give stroke distance. Left ventricular stroke volume was thus calculated from the product of stroke distance with outflow tract cross-sectional area. Thereafter, aortic valve area was calculated with the continuity equation (stroke volume divided by valve flow velocity-time integral as determined by continuous-wave Doppler). The postoperative effective orifice area (EOA) of the aortic prosthesis was calculated by the continuity equation and then indexed to body surface area to assess the presence of PPM.
Of the 339 patients, 222 (65.5%) had preoperative coronary angiography. All angiographies revealed absence of significant coronary artery disease.
Operative technique
All surgical records were reviewed to determine the type and size of aortic valve prosthesis, the surgical procedure performed, the cardioplegic technique employed and crossclamp and cardiopulmonary bypass (CPB) times. Operations were performed by seven surgeons during this 8-year period and the prostheses to implant were used to the discretion of the operating surgeon. 98 bioprostheses and 241 mechanical prostheses were implanted. (Table 1 ).
An isolated aortic valve replacement was performed in all patients. Standard anesthesia and surgical technique, extracorporeal circulation and myocardial protection methods were used. Myocardial protection employed was intermittent cold blood cardioplegia. Most of the patients received both antegrade and retrograde cardioplegia and 'hot-shot' (or reperfusion with warm blood cardioplegia). Lowest core temperature varied from 28 8C to 32 8C depending on individual surgeon's preference. Continuous retrograde perfusion of cold blood was mantained, if possible, during the ischemic period.
Estimation of PPM
Estimation from manufacturer-derived in vitro valve areas: PPM was assessed by calculating the two variables proposed for this purpose, i.e. the indexed EOA derived from the published normal value of EOA for the type and size of the implanted prosthesis divided by the patient's body surface area. Manufacturer-derived in vitro EOA were available in all the patients included in this study allowing classification into two subgroups, with and without mismatch. This method can be used routinely in the operating room as a preventive strategy to avoid PPM. It was used in this study in order to assess the impact of PPM in in-hospital mortality.
On 2 /m 2 or less was considered evidence of mismatch on the basis of previous studies. This parameter was calculated in 220 patients at first month and in 110 patients at first year.
Definitions
Chronic renal insufficiency was defined as a serum creatinine R2 mg/dl. Previous stroke was defined as history of a central neurologic deficit persisting for more than 72 h. Diabetes was defined as a history of diabetes mellitus regardless of its duration or need for oral or insulin treatment. Chronic Obstructive Pulmonary Disease (COPD) was defined as the need for pharmacologic therapy for chronic pulmonary compromise or as a preoperative espirometry with the diagnosis of moderate or severe obstructive pulmonary disease. Urgent operation was considered when the surgical procedure was performed during the hospital stay of an acute clinical episode. Postoperative renal failure was defined as the increase in baseline creatinine value of greater than 2 mg/dl in the absence of end-stage renal failure on dialysis. Respiratory failure was considered as the need for respiratory support for more than 48 h. Low cardiac output syndrome was considered in the analysis when postoperative inotropic support was used for more than 24 h. Finally, in-hospital mortality was defined as death at any time before discharge from the hospital.
Statistics
Statistical analysis was carried out with SPSS 10.0 for Windows. Continuous data are presented as mean G SD if normally distributed or as median and inter-quartile ranges if skewed distributed. Nominal data are presented as frequencies and percentages. Associations among nominal variables were compared by Pearson's c 2 test, continuity correction or 2-sided Fisher exact test as appropriate. Continuous variables were compared by unpaired t-test. Mann-Whitney test was used to compare not normally distributed data. Several preoperative and intraoperative variables were investigated for association with hospital death at univariate analysis using these statistical tests. All variables with a p value of less than 0.10 at univariate analysis were entered in the subsequent multivariate analysis. Stepwise logistic-regression models were used to determine independent predictors of in-hospital mortality with a selection cut-off set at 0.05. Models fit was evaluated using the Hosmer and Lemeshow goodness-offit statistic and residual analysis. Odds ratios, 95% confidence intervals and p values were reported. Area under the receiver-operating characteristic curve (or c-statistic) was calculated as a measure of predictive power. Linear correlations were computed using Pearson's coefficient. A p value less than 0.05 was considered statistically significant. 3. Results
Preoperative and surgical characteristics of study patients
Significant PPM was observed in 129 patients (38%) in the global group. A subgroup of 23 patients (6.8%) had a severe PPM. Univariate comparisons between patients with and without significant PPM are presented in Table 2 . Patients with significant (moderate or severe) mismatch were older and had higher prevalence of female sex, hypertension and smaller prostheses. Larger body surface area and smaller prostheses have been observed as a characteristic association in PPM group. Other demographic characteristics, clinical symptoms, comorbidities and previous cardiovascular risk factors were similar.
The mean indexed EOA in the whole study group was 1.02G0.29 cm 2 /m 2 . The frequency distribution of indexed EOA is reflected in Fig. 1 . The prevalence of significant PPM was different according to the type and size of the implanted prosthesis. Bioprostheses were associated more frequently to significant PPM, 75.5% of the patients with a bioprosthesis (74/98 patients) had at least a moderate mismatch. On the contrary, only 22.8% of those patients with a mechanical valve (55/241) had significant PPM. The higher indexed EOA mean value was obtained in patients who underwent aortic valve replacement with Omnicarbon mechanical prosthesis (1.40G0.25 cm 2 /m 2 ), but this tilting-disc mechanical prosthesis was never implanted in small aortic annulus (%21 mm). On the contrary, the bioprosthesis St Jude Medical Biocor had the lowest index EOA mean value (0.76G0.05 cm 2 /m 2 ) (Fig. 1) . Urgent operations were performed in 9 (4.3%) and 3 (2.3%) patients in both groups (pZ0.51, non-significant vs significant PPM). The mean ischemic and CPB times were similar for both groups. Myocardial protection methods were also similar in both groups during the study period.
Morbidity and hospital stay
Univariate comparisons of postoperative morbidity in both groups of patients are presented in Table 3 . There were no significant differences between groups with respect to most of the common postoperative complications, although low cardiac output syndrome incidence was clearly higher in patients with significant PPM (p!0.01).
Postoperative hospital stay was slightly longer in significant PPM group: a median hospital stay of 12.5 days (interquartile range: 8.0-18.0 days) in contrast to 11.0 days (8.0-15.0 days) in the other group (pZ0.21). Median ICU stay was similar in both groups: 4.0 days (3.0-6.2) and 4.0 days (2.0-6.0) (pZ0.74) in significant versus non-significant PPM group.
Clinical and echocardiographic follow-up: LVMI regression
Clinical and echocardiographic evaluation was obtained in 190 patients at a median of 10 months at follow-up. (Fig. 2a) . Moreover, a significant correlation between preoperative LVMI and absolute postoperative LVMI regression was observed in the global group and, especially, in patients without mismatch. In the presence of PPM this significant correlation was lost (Fig. 2b) . The direct consequence of this impaired LVMI regression in patients with PPM and increased LVMI was a higher postoperative residual left ventricular hypertrophy. In the less favourable setting (i.e. significant PPM and increased LVMI) all patients had residual hypertrophy at follow up. On the contrary, patients with non-significant mismatch and not increased LVMI had a residual hypertrophy incidence of 75 and 65% at first month and at first year, respectively.
In-hospital mortality
In the global group, 13 patients died corresponding to an overall in-hospital mortality of 3.8% (13/339 patients). Mortality was higher in patients with PPM: 5.4% (7/129) versus 2.9% (6/210) (pZ0.36, PPM group with respect to non-significant PPM group). In patients with severe PPM the mortality was even higher: 13.0% (3/23) (p!0.05, with respect to non-significant PPM group). The cause of death was cardiac in all these patients. The main causes of death were: cardiac (3 patients without PPM and 5 patients in PPM group), renal failure (1 patient in each group), sepsis and multiorgan failure (1 patient in each group) and neurologic (1 patient in non-significant PPM group). Increased LVMI was also associated to a higher mortality in the global group: 8.4% (7/83) versus 2.3% (6/256) (p!0.05, increased LVMI with respect to not increased LVMI). Particularly, in patients with PPM the impact of increased LVMI on in-hospital mortality was more evident than in the absence of significant PPM (Fig. 3) . Patients with low LVEF (LVEF%50%) had a higher mortality in the global group: 10% (6/60) vs 2.5 (7/279) (p!0.05, LVEF%50% with respect to patients with LVEFO50%). These patients also had a higher mortality in the presence of PPM (but statistically not significant). Moreover, the double association of increased LVMI and low LVEF was shown to be particularly delitereous on in-hospital mortality (Fig. 3) .
Statistically significant univariate associations to mortality and independent predictors of mortality identified from a subsequent multivariate logistic model are presented in Table 5 . Prosthesis type and size were investigated for association with in-hospital death at univariate analysis but no evidence of statistically significant association was found. On the contrary, the influence of increased LVMI (superior quartile) on in-hospital mortality was evident in the regression model obtained in the global group. Unlike increased LVMI, severe PPM was not an independent predictor of mortality in the global group. In the subgroup 
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.94, dfZ2, pZ0.37) with a good predictive power (area under the ROC curve: 0.77).
Discussion
In patients with a small aortic annulus it is usually difficult to implant sufficiently large valve prostheses. PPM is the immediate consequence of this situation. This mismatch was first defined by Rahimtoola as being present when the EOA of the prosthesis being implanted is less than that of the normal human valve [10] . Based on this definition, most patients undergoing aortic valve replacement would have at least mild PPM.
In the present study, indexed EOA has been employed to estimate PPM. Nowadays, the indexed EOA is the only parameter yet demonstrated as being valid to identify PPM [11] . This mismatch is considered as not clinically significant (i.e. mild or no PPM) if the indexed EOA is O0.85 cm 2 [5] . On the contrary, several previous studies have defined PPM on the basis of the indexed internal geometric area calculated from the anatomically measured internal diameter of the prosthesis divided by the patient's body surface area [2, 12] . However, other important reports have shown that this parameter overestimates EOA in varying proportions depending on prosthesis type and geometry [11] .
In our current practice, we have a high proportion of patients with aortic stenosis and small aortic annulus. We have described a series of 339 patients from a geographically well defined area who underwent consecutively aortic valve replacement during an 8 year period (Mar-94 to Nov-01). Elderly Spanish patients have a particular demographic characteristic: a very low body surface area and a high prevalence of small aortic annulus. The insertion of a small prosthesis into these aged patients is usually a challenging operation. The higher incidence of PPM and the more complex surgical alternatives to small valve implantation (ie, stentless, homografts or aortic root enlargement) are factors of increasing operative risk in these difficult patient population.
We have been restrictive with the patient selection criteria considered in this study. It is very important to obtain a homogeneous group of patients and to avoid confounding factors in order to address the impact of PPM on in-hospital mortality. Unfortunately, previous studies have been based on inhomogeneous groups of patients [5] . Significant aortic valve regurgitation, coronary artery bypass grafting, infectious endocarditis, emergent or redo operations have not been considered as exclusion criteria by most of these reports. Several of these factors have been previously found as independent predictors of short-term mortality related to aortic valve replacement: emergent operation, infectious endocarditis, associated coronary artery disease, recent myocardial infarction and other factors as age, female gender, poor left ventricular ejection fraction, diabetes, hypertension, left ventricular hypertrophy or small prosthetic valves [6, [13] [14] [15] . Therefore, we have selected patients who underwent isolated aortic valve replacement because of pure or predominant aortic valve stenosis and several exclusion criteria have been considered: aortic regurgitation, emergent operation, infectious endocarditis, coronary artery disease and concomitant surgical procedures other than aortic valve replacement.
The real impact of PPM on survival remains controversial, particularly the relation between PPM and short-term mortality [5] . Many previous reports have considered PPM as negligible because this is an unfrequent phenomenon [16] and/or because its presence do not affect negatively clinical outcomes [1, 2, 15] . On the contrary, Blais et al. [5] reported a dramatic increase in mortality risk due to the combination of poor left ventricular function and moderate-severe PPM. This result is indirectly consistent with the study by Connolly et al. [14] , that reported a markedly higher mortality (47 vs 15%; pZ0.03) in patients with aortic stenosis and severely depressed myocardial contractility (LVEF %35%) receiving a small prosthesis (%21 mm) as compared with a larger prosthesis. In the former study the authors suggested that the greatest impact of PPM with regards to survival was in the early postoperative period when the left ventricle is most vulnerable [5] . A natural selection process at that time of operation during which many patients at risk do not survive beyond the early postoperative period could explain the relatively better prognosis of moderate-severe PPM beyond that critical period. These findings are really important given that moderate-severe PPM is not unfrequent with a prevalence between 19 and 70% being reported in the literature [17, 18] (38% in our patients).
Other factors as high degree of left ventricular hypertrophy could be important in this early operative phase given that the left ventricle is more vulnerable and sensitive to the increased hemodynamic exigence imposed by PPM. Moreover, as this mismatch has been shown to seriously hamper left ventricular mass regression after aortic valve replacement [19] , it would be of great interest to determine if PPM is not only important in patients with left ventricular dysfunction but also in those with higher degrees of left ventricular hypertrophy. Therefore, in the present study we have evaluated not only the influence of PPM on in-hospital mortality, but its impact on left ventricular mass regression in patients with preoperatively increased LVMI. Most patients had a preoperative echocardiogram performed at our institution and LVMI values were available in all of them. Previous studies have reported the prognostic importance of increased LVMI early and late after aortic valve replacement [6, 7] . Indeed, we have evidenced a significant increased in in-hospital mortality in patients with high LVMI in the presence of PPM. Without mismatch, increased LVMI was not associated to a significant higher mortality. Moreover, PPM was not found as an independent predictor of mortality by itself, but it has been a promoter factor of LVMI impact on mortality. Thus, in the subgroup of patients with mismatch, increased LVMI was the strongest predictor of mortality. On the contrary, Blais et al. [5] found that PPM was an independent risk factor directly associated to short-term mortality. In our experience, the negative influence of PPM on short-term mortality in patients with left ventricular dysfunction was not as evident as the impact observed in patients with increased LVMI. But the triple association of PPM, increased LVMI and low LVEF may be particularly deletereous on in-hospital mortality. In our study, inhospital mortality in patients with increased LVMI and LVEF%50% has been very high (26.3%) (Fig. 3) . This link between increased ventricular mass and depressed LVEF was observed in a multicenter study [20] . An increased left ventricular mass was found as an independent risk factor for depressed left ventricular function. Therefore, these three factors, significant PPM, increased LVMI and low LVEF, may be linked all together in close association with mortality.
Moreover, in absence of mismatch, postoperative absolute LVMI regression was proportional to the preoperative LVMI level, i.e. this regression was higher in patients with higher basal degree of left ventricular hypertrophy. On the contrary, if PPM was present, LVMI regression was impaired, especially in those patients with higher LVMI values. This worse regression was reflected on a higher residual hypertrophy at follow-up (100% incidence when both factors were present).
In conclusion, in patients with severe left ventricular hypertrophy it may be important to elude PPM after aortic valve replacement to avoid a significant increase in mortality and improve left ventricular mass regression. Particularly, high-risk patients with elevated LVMI and low LVEF may have a marked increase in this mortality. Therefore, this mismatch may be tolerable in patients with lesser degree of hypertrophy.
Limitations of the study
A number of limitations are inherent to this analysis design: a retrospective single institution study. Although strict selection criteria were used to obtain a homogeneous group of patients, a retrospective analysis is susceptible to various sources of bias which may have not been identified and controlled. Thus, the decision to implant a specific valve prosthesis was not based on well defined preoperative criteria, but solely on surgeon preference. A wide variety of prostheses have been used including bioprostheses and mechanical prostheses. This fact may be also considered as a major limitation.
Another limitation of the present study is the long time period of the analysis (8 years); changes in surgical techniques and intraoperative myocardial protection methods along time may influence outcome and prognostic factors.
A further study limitation may be the method of LVMI evaluation. Although echocardiography is a usual diagnostic tool for LVMI estimation, magnetic resonance imaging provides a more reliable quantification of left ventricular hypertrophy regression.
